Stock Track | Haemonetics Soars 8.22% in Pre-market on Strong Q4 Earnings Beat and Upbeat Fiscal 2027 Guidance

Stock Track

May 07

Haemonetics Corporation's stock surged 8.22% in pre-market trading on Thursday, following the release of its fourth-quarter fiscal 2026 financial results that exceeded analyst expectations.

The medical technology company reported adjusted earnings per share of $1.29 for the quarter, surpassing the FactSet consensus estimate of $1.27. Quarterly net revenue reached $346.4 million, also beating the expected $336.8 million and representing growth from the $330.6 million reported a year earlier.

Additionally, Haemonetics provided a positive outlook for fiscal 2027, guiding for reported revenue growth in the range of 4% to 7%. The company stated that adjusted diluted earnings per share for the fiscal year are expected to be comparable to this revenue growth rate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1179427811"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179427811\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179427811?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179427811","market":"us","top_or_hot":-1,"title":"Stock Track | Haemonetics Soars 8.22% in Pre-market on Strong Q4 Earnings Beat and Upbeat Fiscal 2027 Guidance","media":"Stock Track","content":"<p>Haemonetics Corporation's stock surged 8.22% in pre-market trading on Thursday, following the release of its fourth-quarter fiscal 2026 financial results that exceeded analyst expectations.</p><p>The medical technology company reported adjusted earnings per share of $1.29 for the quarter, surpassing the FactSet consensus estimate of $1.27. Quarterly net revenue reached $346.4 million, also beating the expected $336.8 million and representing growth from the $330.6 million reported a year earlier.</p><p>Additionally, Haemonetics provided a positive outlook for fiscal 2027, guiding for reported revenue growth in the range of 4% to 7%. The company stated that adjusted diluted earnings per share for the fiscal year are expected to be comparable to this revenue growth rate.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Haemonetics Soars 8.22% in Pre-market on Strong Q4 Earnings Beat and Upbeat Fiscal 2027 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Haemonetics Soars 8.22% in Pre-market on Strong Q4 Earnings Beat and Upbeat Fiscal 2027 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-07 20:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Haemonetics Corporation's stock surged 8.22% in pre-market trading on Thursday, following the release of its fourth-quarter fiscal 2026 financial results that exceeded analyst expectations.</p><p>The medical technology company reported adjusted earnings per share of $1.29 for the quarter, surpassing the FactSet consensus estimate of $1.27. Quarterly net revenue reached $346.4 million, also beating the expected $336.8 million and representing growth from the $330.6 million reported a year earlier.</p><p>Additionally, Haemonetics provided a positive outlook for fiscal 2027, guiding for reported revenue growth in the range of 4% to 7%. The company stated that adjusted diluted earnings per share for the fiscal year are expected to be comparable to this revenue growth rate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HAE","symbol_name":"美国血液技术","start_time":0,"source_url":"","article_id":"1179427811","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179427811","pubTimestamp":1778156669,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Haemonetics Corporation's stock surged 8.22% in pre-market trading on Thursday, following the release of its fourth-quarter fiscal 2026 financial results that exceeded analyst expectations.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HAE":"美国血液技术"},"translate_title":"股票追踪|Haemonetics盘前飙升8.22%，第四季度盈利强劲，2027财年指引乐观","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HAE":1},"content_text":"Haemonetics Corporation's stock surged 8.22% in pre-market trading on Thursday, following the release of its fourth-quarter fiscal 2026 financial results that exceeded analyst expectations.The medical technology company reported adjusted earnings per share of $1.29 for the quarter, surpassing the FactSet consensus estimate of $1.27. Quarterly net revenue reached $346.4 million, also beating the expected $336.8 million and representing growth from the $330.6 million reported a year earlier.Additionally, Haemonetics provided a positive outlook for fiscal 2027, guiding for reported revenue growth in the range of 4% to 7%. The company stated that adjusted diluted earnings per share for the fiscal year are expected to be comparable to this revenue growth rate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}